SBF
TCRT icon

Sara-Bay Financial’s Alaunos Therapeutics TCRT Stock Holding History

Sara-Bay Financial’s Portfolio TCRT Stock Details TCRT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-67
Closed -$25K – 78
2020
Q3 		$25K Hold
67
– – 0.01% 74
2020
Q2 		$31.6K Buy
+67
New +$29.9K 0.02% 76

Other funds holding TCRT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MP
MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return
MVP
Miller Value Partners Sarasota, Florida $383M AUM 38.57% 1-Year Est. Return
DCM
Discovery Capital Management South Norwalk, Connecticut $1.92B AUM 218.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Sara-Bay Financial's TCRT Position: Q4 2020 in Review

Sara-Bay Financial sold out of Alaunos Therapeutics (TCRT) in Q4 2020, closing a stake of 67 shares — an estimated $25K sold.

Sara-Bay Financial first reported a position in TCRT in Q2 2020 and held it in 2 quarters. The position peaked at $31.6K in Q2 2020. 156 funds tracked by Wall St. Rank hold TCRT as of Q4 2020.

  • Sara-Bay Financial reported no remaining Alaunos Therapeutics position as of Q4 2020 after selling out during the quarter.
  • Sara-Bay Financial sold 67 Alaunos Therapeutics shares in Q4 2020, an estimated $25K.
  • Sara-Bay Financial first reported a position in Alaunos Therapeutics in Q2 2020 and held it in 2 quarters.
  • Sara-Bay Financial's Alaunos Therapeutics position peaked at $31.6K in Q2 2020.
  • 156 funds tracked by Wall St. Rank held Alaunos Therapeutics as of Q4 2020.

Based on Sara-Bay Financial's 13F filing for Q4 2020, filed 15 Jan 2021.